The plasma concentrations of IL-20 and IL-24 were significantly increased in early RA patients compared with HCs (P = 0.0002 and P = 0.0016, respectively) and decreased after 6 months of treatment (both P < 0.0001) (Fig. 1a). This evidence concerns the gene IL20 and rheumatoid arthritis.